Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Transcriptomics Technologies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transcriptomics Technologies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transcriptomics Technologies Overall Market Size
2.1 Global Transcriptomics Technologies Market Size: 2022 VS 2030
2.2 Global Transcriptomics Technologies Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Transcriptomics Technologies Players in Global Market
3.2 Top Global Transcriptomics Technologies Companies Ranked by Revenue
3.3 Global Transcriptomics Technologies Revenue by Companies
3.4 Top 3 and Top 5 Transcriptomics Technologies Companies in Global Market, by Revenue in 2022
3.5 Global Companies Transcriptomics Technologies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Transcriptomics Technologies Players in Global Market
3.6.1 List of Global Tier 1 Transcriptomics Technologies Companies
3.6.2 List of Global Tier 2 and Tier 3 Transcriptomics Technologies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Transcriptomics Technologies Market Size Markets, 2022 & 2030
4.1.2 Microarrays
4.1.3 Polymerase Chain Reaction (PCR)
4.1.4 Gene Regulation Technologies
4.1.5 Next Generation Sequencing (NGS)
4.2 By Type - Global Transcriptomics Technologies Revenue & Forecasts
4.2.1 By Type - Global Transcriptomics Technologies Revenue, 2018-2023
4.2.2 By Type - Global Transcriptomics Technologies Revenue, 2024-2030
4.2.3 By Type - Global Transcriptomics Technologies Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Transcriptomics Technologies Market Size, 2022 & 2030
5.1.2 Clinical Diagnostics
5.1.3 Drug Discovery and Research
5.1.4 Bioinformatics
5.1.5 Comparative Transcriptomics Studies
5.2 By Application - Global Transcriptomics Technologies Revenue & Forecasts
5.2.1 By Application - Global Transcriptomics Technologies Revenue, 2018-2023
5.2.2 By Application - Global Transcriptomics Technologies Revenue, 2024-2030
5.2.3 By Application - Global Transcriptomics Technologies Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Transcriptomics Technologies Market Size, 2022 & 2030
6.2 By Region - Global Transcriptomics Technologies Revenue & Forecasts
6.2.1 By Region - Global Transcriptomics Technologies Revenue, 2018-2023
6.2.2 By Region - Global Transcriptomics Technologies Revenue, 2024-2030
6.2.3 By Region - Global Transcriptomics Technologies Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Transcriptomics Technologies Revenue, 2018-2030
6.3.2 US Transcriptomics Technologies Market Size, 2018-2030
6.3.3 Canada Transcriptomics Technologies Market Size, 2018-2030
6.3.4 Mexico Transcriptomics Technologies Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Transcriptomics Technologies Revenue, 2018-2030
6.4.2 Germany Transcriptomics Technologies Market Size, 2018-2030
6.4.3 France Transcriptomics Technologies Market Size, 2018-2030
6.4.4 U.K. Transcriptomics Technologies Market Size, 2018-2030
6.4.5 Italy Transcriptomics Technologies Market Size, 2018-2030
6.4.6 Russia Transcriptomics Technologies Market Size, 2018-2030
6.4.7 Nordic Countries Transcriptomics Technologies Market Size, 2018-2030
6.4.8 Benelux Transcriptomics Technologies Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Transcriptomics Technologies Revenue, 2018-2030
6.5.2 China Transcriptomics Technologies Market Size, 2018-2030
6.5.3 Japan Transcriptomics Technologies Market Size, 2018-2030
6.5.4 South Korea Transcriptomics Technologies Market Size, 2018-2030
6.5.5 Southeast Asia Transcriptomics Technologies Market Size, 2018-2030
6.5.6 India Transcriptomics Technologies Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Transcriptomics Technologies Revenue, 2018-2030
6.6.2 Brazil Transcriptomics Technologies Market Size, 2018-2030
6.6.3 Argentina Transcriptomics Technologies Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Transcriptomics Technologies Revenue, 2018-2030
6.7.2 Turkey Transcriptomics Technologies Market Size, 2018-2030
6.7.3 Israel Transcriptomics Technologies Market Size, 2018-2030
6.7.4 Saudi Arabia Transcriptomics Technologies Market Size, 2018-2030
6.7.5 UAE Transcriptomics Technologies Market Size, 2018-2030
7 Transcriptomics Technologies Companies Profiles
7.1 Affymetrix, Inc.
7.1.1 Affymetrix, Inc. Company Summary
7.1.2 Affymetrix, Inc. Business Overview
7.1.3 Affymetrix, Inc. Transcriptomics Technologies Major Product Offerings
7.1.4 Affymetrix, Inc. Transcriptomics Technologies Revenue in Global Market (2018-2023)
7.1.5 Affymetrix, Inc. Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Transcriptomics Technologies Major Product Offerings
7.2.4 Thermo Fisher Scientific Transcriptomics Technologies Revenue in Global Market (2018-2023)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Company Summary
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies Transcriptomics Technologies Major Product Offerings
7.3.4 Agilent Technologies Transcriptomics Technologies Revenue in Global Market (2018-2023)
7.3.5 Agilent Technologies Key News & Latest Developments
7.4 F-Hoffmann La Roche Ltd.
7.4.1 F-Hoffmann La Roche Ltd. Company Summary
7.4.2 F-Hoffmann La Roche Ltd. Business Overview
7.4.3 F-Hoffmann La Roche Ltd. Transcriptomics Technologies Major Product Offerings
7.4.4 F-Hoffmann La Roche Ltd. Transcriptomics Technologies Revenue in Global Market (2018-2023)
7.4.5 F-Hoffmann La Roche Ltd. Key News & Latest Developments
7.5 Illumina, Inc.
7.5.1 Illumina, Inc. Company Summary
7.5.2 Illumina, Inc. Business Overview
7.5.3 Illumina, Inc. Transcriptomics Technologies Major Product Offerings
7.5.4 Illumina, Inc. Transcriptomics Technologies Revenue in Global Market (2018-2023)
7.5.5 Illumina, Inc. Key News & Latest Developments
7.6 Life Technologies Corporation
7.6.1 Life Technologies Corporation Company Summary
7.6.2 Life Technologies Corporation Business Overview
7.6.3 Life Technologies Corporation Transcriptomics Technologies Major Product Offerings
7.6.4 Life Technologies Corporation Transcriptomics Technologies Revenue in Global Market (2018-2023)
7.6.5 Life Technologies Corporation Key News & Latest Developments
7.7 Qiangen N.V.
7.7.1 Qiangen N.V. Company Summary
7.7.2 Qiangen N.V. Business Overview
7.7.3 Qiangen N.V. Transcriptomics Technologies Major Product Offerings
7.7.4 Qiangen N.V. Transcriptomics Technologies Revenue in Global Market (2018-2023)
7.7.5 Qiangen N.V. Key News & Latest Developments
7.8 LC Sciences
7.8.1 LC Sciences Company Summary
7.8.2 LC Sciences Business Overview
7.8.3 LC Sciences Transcriptomics Technologies Major Product Offerings
7.8.4 LC Sciences Transcriptomics Technologies Revenue in Global Market (2018-2023)
7.8.5 LC Sciences Key News & Latest Developments
7.9 Sigma-Aldrich Corp
7.9.1 Sigma-Aldrich Corp Company Summary
7.9.2 Sigma-Aldrich Corp Business Overview
7.9.3 Sigma-Aldrich Corp Transcriptomics Technologies Major Product Offerings
7.9.4 Sigma-Aldrich Corp Transcriptomics Technologies Revenue in Global Market (2018-2023)
7.9.5 Sigma-Aldrich Corp Key News & Latest Developments
7.10 Danaher Corp
7.10.1 Danaher Corp Company Summary
7.10.2 Danaher Corp Business Overview
7.10.3 Danaher Corp Transcriptomics Technologies Major Product Offerings
7.10.4 Danaher Corp Transcriptomics Technologies Revenue in Global Market (2018-2023)
7.10.5 Danaher Corp Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer